Biological features and clinical outcomes in atezolizumab (atezo)-treated patients (pts) with metastatic urothelial cancer (mUC) of the upper vs lower urinary tract (UTUC vs LTUC) Meeting Abstract
| Authors: | Galsky, M. D.; Banchereau, R.; Kadel, E. E. 3rd; Ramirez-Montagut, T.; Mariathasan, S.; Thåström, A.; Rosenberg, J.; Powles, T.; van der Heijden, M. S.; Necchi, A. |
| Abstract Title: | Biological features and clinical outcomes in atezolizumab (atezo)-treated patients (pts) with metastatic urothelial cancer (mUC) of the upper vs lower urinary tract (UTUC vs LTUC) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy283.111 |
| Language: | English |
| ACCESSION: | WOS:000459277302085 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy283.111 |
| Notes: | Meeting Abstract: 902P -- Appears on page viii321 of the abstract book -- Source: Wos |
